Nuvectis Pharma Inc. (NVCT): Price and Financial Metrics Recent IPO


Nuvectis Pharma Inc. (NVCT): $11.61

-0.50 (-4.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NVCT Stock Price Chart Interactive Chart >

Price chart for NVCT

NVCT Price/Volume Stats

Current price $11.61 52-week high $20.92
Prev. close $12.11 52-week low $3.08
Day low $11.61 Volume 1,362
Day high $11.75 Avg. volume 942,825
50-day MA $13.06 Dividend yield N/A
200-day MA $0.00 Market Cap 147.66M

Nuvectis Pharma Inc. (NVCT) Company Bio


Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.


NVCT Latest News Stream


Event/Time News Detail
Loading, please wait...

NVCT Latest Social Stream


Loading social stream, please wait...

View Full NVCT Social Stream

NVCT Price Returns

1-mo N/A
3-mo 56.68%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5418 seconds.